|
Este producto existe y está activo pero no existe en el idioma actualmente seleccionado.
|
.
EDITOR-IN-CHIEF
Prof. I. Yakoub-Agha, Dept. of Haematology, Head of the Immune Cellular Therapy Unit, Lille University Hospital, Lille, France
EDITORS
Dr T. Alsuliman, Dept. of Haematology and cellular therapy, Saint-Antoine hospital, APHP, Paris ; Sorbonne University, Paris, France
Prof. M. Beksac, Dept. of Hematology, Ankara University, Ankara, Turkey
Prof. H. Bönig, Dept of Translational Development of Cellular Therapeutics, Institute for Transfusion Medicine and Immune Hematology, Johann-Wolfgang-Goethe Medical University, Frankfurt, Germany
Dr E. Brissot, Dept. of Haematology and cellular therapy, Saint-Antoine hospital, APHP, Paris ; Sorbonne University, Paris, France
Prof. G. Damaj, Dept. of Haematology, Caen University Hospital, Caen, France
Dr J. Demaret, Lille University Hospital, Lille, France
Dr R. Greco, Blood and Marrow Transplant Unit (BMT), San Raffaele Scientific Hospital (IRCCS), Milano, Italy
Prof. M. Guzman, Weill Cornell Medicine, New York, USA
Dr P. Hayden, St. James's hospital, Dublin, Ireland
Dr D. Humaidan, Eberhard Karls University of Tuebingen and Max Planck International Research School for Intelligent Systems (IMPRS-IS), Tuebingen, Germany
Prof. M. Ahmad Kassab, Research Associate, University of Pennsylvanian, Philadelphia, Pennsylvania, USA
Prof. M. Labalette, Lab of Immunology and HLA, Lille University Hospital, Lille, France
Prof. J. Larghero, Saint Louis Hospital, Paris, France
Prof. J. J. Melenhorst, University of Pennsylvania, Philadelphia, United States
Dr C. Roddie, University of London, London, UK
Prof. J. A Snowden, Consultant Haematologist & Director of Blood and Marrow Transplantation, Sheffi eld Teaching Hospitals NHS Foundation Trust Sheffi eld, UK
Prof. M. Subklewe, LMU University Hospital Munich, Munich, Germany
Dr A. Sureda, Blood Cell Barcelona Hematology Institute, Barcelona, Spain
.
BIOSTATISTICIAN
Dr M. Ordak, Centre for Preclinical, Research and Technology (CePT), Medical University of Warsaw, Poland
.
INTERNATIONAL SCIENTIFIC COMMITTEE
R. Burt (Northwestern University Feinberg School of Medicine, Chicago, United States), F. Calvo (INSERM U749, Villejuif, France), O. Cohen Haguenauer (University Institute of Geriatry of Sherbrooke, Paris, France), T. Fülop (Sherbrooke University of Applied Sciences Institute, Quebec, Canada), M.-P. Jacob-Lenet (INSERM, Cardiovascular Structural Diseases, Paris, France), M. Leboyer (University Hospital Centre Henri Mondor, Créteil, France), F.-X. Maquart (University Hospital Centre Reims Biochemistry Laboratory, Reims, France), J.-M. Molina (Saint Louis Hospital, Paris, France), J.-C. Monboisse (University Hospital Centre Reims Biochemistry Laboratory, Reims, France), N. Mazure (Nice, France)
Current Research in Translational Medicine. Cellular and Immune Therapy is a peer-reviewed journal, publishing worlwide clinical and basic research in the field of hematology, immunology, hematopoietic cell transplantation, and cellular and gene therapy. The journal considers for publication English-language editorials, original articles, reviews, and short reports including case-reports. Contributions are intended to draw attention to experimental medicine and translational research. Current Research in Translational Medicine periodically publishes thematic issues and is indexed in all major international databases. 2023 Impact Factor: 3.2. Source: 2023 Journal Citation Reports (Clarivate Analytics, 2024). 4 issues/year. E-journal
Current Research in Translational Medicine. Cellular and Immune Therapy is a peer-reviewed journal, publishing worlwide clinical and basic research in the field of hematology, immunology, hematopoietic cell transplantation, and cellular and gene therapy. The journal considers for publication English-language editorials, original articles, reviews, and short reports including case-reports. Contributions are intended to draw attention to experimental medicine and translational research. Current Research in Translational Medicine periodically publishes thematic issues and is indexed in all major international databases. 2023 Impact Factor: 3.2. Source: 2023 Journal Citation Reports (Clarivate Analytics, 2024). 4 issues/year. E-journal
2023 Impact Factor*: 3.2
*2023 Journal Citation Reports (Clarivate Analytics, 2024)
EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.
En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.
Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.
